Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Translational neuroimaging: positron emission tomography studies of monoamine oxidase.

Fowler JS, Logan J, Volkow ND, Wang GJ.

Mol Imaging Biol. 2005 Nov-Dec;7(6):377-87. Review.

PMID:
16265597
2.
3.

Monoamine oxidase: radiotracer development and human studies.

Fowler JS, Logan J, Volkow ND, Wang GJ, MacGregor RR, Ding YS.

Methods. 2002 Jul;27(3):263-77. Review.

PMID:
12183115
4.

Comparison of monoamine oxidase a in peripheral organs in nonsmokers and smokers.

Fowler JS, Logan J, Wang GJ, Volkow ND, Telang F, Zhu W, Franceschi D, Shea C, Garza V, Xu Y, Ding YS, Alexoff D, Warner D, Netusil N, Carter P, Jayne M, King P, Vaska P.

J Nucl Med. 2005 Sep;46(9):1414-20.

5.

PET imaging of monoamine oxidase B in peripheral organs in humans.

Fowler JS, Logan J, Wang GJ, Volkow ND, Zhu W, Franceschi D, Pappas N, Ferrieri R, Shea C, Garza V, Xu Y, MacGregor RR, Schlyer D, Gatley SJ, Ding YS, Alexoff D.

J Nucl Med. 2002 Oct;43(10):1331-8.

6.
7.
8.

Reversible inhibitors of monoamine oxidase-A (RIMAs): robust, reversible inhibition of human brain MAO-A by CX157.

Fowler JS, Logan J, Azzaro AJ, Fielding RM, Zhu W, Poshusta AK, Burch D, Brand B, Free J, Asgharnejad M, Wang GJ, Telang F, Hubbard B, Jayne M, King P, Carter P, Carter S, Xu Y, Shea C, Muench L, Alexoff D, Shumay E, Schueller M, Warner D, Apelskog-Torres K.

Neuropsychopharmacology. 2010 Feb;35(3):623-31. doi: 10.1038/npp.2009.167. Epub 2009 Nov 4.

9.
10.
11.

In vivo measurement of brain monoamine oxidase B occupancy by rasagiline, using (11)C-l-deprenyl and PET.

Freedman NM, Mishani E, Krausz Y, Weininger J, Lester H, Blaugrund E, Ehrlich D, Chisin R.

J Nucl Med. 2005 Oct;46(10):1618-24.

12.
13.

The monoamine oxidase type B inhibitor rasagiline in the treatment of Parkinson disease: is tyramine a challenge?

Chen JJ, Wilkinson JR.

J Clin Pharmacol. 2012 May;52(5):620-8. doi: 10.1177/0091270011406279. Epub 2011 May 31. Review.

PMID:
21628600
14.

In Vivo Metabolic Trapping Radiotracers for Imaging Monoamine Oxidase-A and -B Enzymatic Activity.

Brooks AF, Shao X, Quesada CA, Sherman P, Scott PJ, Kilbourn MR.

ACS Chem Neurosci. 2015 Dec 16;6(12):1965-71. doi: 10.1021/acschemneuro.5b00223. Epub 2015 Oct 1.

15.

[Monoamine oxidase as a target for drug action].

Drozak J, Kozłowski M.

Postepy Hig Med Dosw (Online). 2006;60:498-515. Review. Polish.

17.

A and B forms of monoamine oxidase within the monoaminergic neurons of the rat brain.

Fagervall I, Ross SB.

J Neurochem. 1986 Aug;47(2):569-76.

PMID:
3734795
18.

Properties of monoamine oxidase in monkey heart.

Katayama M, Kobayashi S, Oguchi K, Yasuhara H.

Jpn J Pharmacol. 1984 Aug;35(4):425-31.

19.

Inhibitor design for monoamine oxidases.

Ramsay RR.

Curr Pharm Des. 2013;19(14):2529-39. Review.

PMID:
23116392
20.

Monoamine oxidase: radiotracer chemistry and human studies.

Fowler JS, Logan J, Shumay E, Alia-Klein N, Wang GJ, Volkow ND.

J Labelled Comp Radiopharm. 2015 Mar;58(3):51-64. doi: 10.1002/jlcr.3247. Epub 2015 Feb 10. Review.

PMID:
25678277

Supplemental Content

Support Center